Skip to main content
Premium Trial:

Request an Annual Quote

The BioCommerce Week Index: Jul 7, 2006

Qiagen Added to the BCW Index; BD Dropped on Clontech Sale

This week marks the first roster change in BioCommerce Week's 10-month existence. Qiagen, a multi-platform molecular biology tools provider, competes with many of the players already covered by BioCommerce Week and has partnerships with others. The company has been very active in the molecular biology tools space and has made several moves this year to expand its product range and geographic reach (see table below). As such, the Dutch firm has been added to the Index.

Becton Dickinson, on the other hand, was tracked by this publication solely because of its ownership of Clontech. Now that BD has announced an agreement to sell the unit to Japanese firm Takara (see article in this week's issue), the firm does not meet the criteria for inclusion in the Index and will no longer receive routine coverage.

This week's Index has been adjusted to reflect Qiagen's participation. For the four-day trading period ended July 5 (the markets were closed for the July 4 holiday), the BCW Index rose .83 percent, nearly matching the Nasdaq Biotech Index's increase of .82 percent for the same period. The broader Nasdaq market gained .43 percent for the week, while the Dow Jones Industrial Average dropped .33 percent.

For the first six months of 2005, the Index, which included BD but not Qiagen, gained a miniscule .23 percent. The high for the Index during that time was 36.10, reached on Feb. 8, and the low was 32.89 on April 19 (see chart).

BioCommerce Week’s Index to the
Diversified Molecular Biology Tools Companies
Company
Ticker
Current Price
(
July 5, 2005)
Last Price
(
June 28 , 2005)
% Change
Agilent
A
23.62
23.49
0.55
Applied Biosystems
ABI
20.31
20.12
0.94
Beckman
BEC
64.96
63.26
2.69
Bio-Rad
BIO
58.85
59.39
-0.91
Bruker
BRKR
4.13
4.11
0.49
GE
GE
34.72
35.15
-1.22
Harvard Bio
HBIO
3.18
3.15
0.95
Invitrogen
IVGN
84.9
83.14
2.12
Molecular Devices
MDCC
21.8
21.36
2.06
PerkinElmer
PKI
19.7
18.75
5.07
Qiagen
QGEN
11.95
11.9
0.42
Sigma
SIAL
55.99
56.97
-1.72
Strategene
STGN
8.59
8.61
-0.23
Thermo
TMO
26.73
26.75
-0.07
Waters
WAT
38.49
37.84
1.72
Index Average
31.86
31.60
0.83

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.